SEP 13 2002
510(k) SUMMARY KOA147I~
ASCLEPION-MEDITEC AG
Laser System BeautyStar 532

This 510(k) summary of safety and effectiveness for the ASCLEPION-MEDITEC AG

Laser System BeautyStar 532 is submitted in accordance with the requirements of

SDMA 1990 and follows Office of Device Evaluation Guidance concerning the

organization and content of a 510(k) summary.

Applicant. ASCLEPION-MEDITEC AG

Address: Goeschwitzer Strasse 51-52

07745 Jena, Germany

Contact Person: _ Dr. Dirk Colditz
Vice President Operations and
International Regulatory Affairs

Phone: +49 3641 220 501

Fax: +49 3641 220 502

e-mail: ctz@asclepion.com

Preparation date: Mai 23", 2002

Device name: Laser System BeautyStar 532

Common Name: BeautyStar 532

Classification

Name: Laser surgical instrument for use in general and plastic

surgery
and in dermatology (21 CFR 878.4810)

Product code: GEX — Laser instrument, surgical, powered
Panel: 79

Legally marketed: in the European Community based on CE-Mark

Description: The Laser System BeautyStar 532 consists of a laser enclosure,

fiber
optic delivery system and an computer controlled treatment
parameter interface.

Intended Use: The laser system BeautyStar 532 intended for vaporization and
photocoagulation of vascular and pigmented lesions in soft
tissue.

Comparison to: The specifications of the BeautyStar 532 are the same as or
very similar to those of legally marketed lasers such as the HGM
Atlas-Elite, Model E-80, Corium 200/400 (K990174), Laserscope

File.510K SUMMARY BeautyStar DOC Page 1 of 2

FICINAIREL NULITIGALION! DEAULyOLa!l JIL rage 04 O1 90

Aura (K951034), Medart Corp. MedArt 470(K010885), Iridex
Corp. DioLite 532 (K964074, Ceramoptec Ceralase
G15(K002296) and Quantel Medical Viridis Derm (K02007 1)

Performance data: None. The specifications and intended uses of the laser system
BeautyStar 532 are the same or very similar to those of claimed
predicate devices.
Because of this , performance data were not required.

CONCLUSION: The BeautyStar 532 is substantially equivalent to legally
marketed devices.

File:510K SUMMARY BesulyStar.DOC Pane ? of 2

p m4 DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service
Mount Food and Drug Administration
9200 Corporate Boulevard
Rockville MD 20850

Asclepion-Meditee AG
William Kelley
c/o Asclepion-Meditec, Inc.
8884 Warner Avenue, Suite 167 SEP 13 2002
Fountain Valley, California 92708
Re: K021975

Trade/Device Name: Laser System BeautyStar 532

Regulation Number: 878.4810

Regulation Name: Laser surgical instrument for use in general and plastic surgery and in

dermatology

Regulatory Class: Class I

Product Code: GEX

Dated: May 20, 2002

Received: June 17, 2002
Dear Mr. Kelley:
We have reviewed your Section 510(k) premarket notification of intent to market the device
referenced above and have determined the device is substantially equivalent (for the indications
for use stated in the enclosure) to legally marketed predicate devices marketed in interstate
commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to
devices that have been reclassified in accordance with the provisions of the Federal Food, Drug,
and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA).
You may, therefore, market the device, subject to the general controls provisions of the Act. The
general controls provisions of the Act include requirements for annual registration, listing of
devices, good manufacturing practice, labeling, and prohibitions against misbranding and
adulteration.
If your device is classified (see above) into either class II (Special Controls) or class II] (PMA), it
may be subject to such additional controls. Existing major regulations affecting your device can
be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may
publish further announcements concerning your device in the Federal Register.
Please be advised that FDA’s issuance of a substantial equivalence determination does not mean
that FDA has made a determination that your device complies with other requirements of the Act
or any Federal statutes and regulations administered by other Federal agencies. You must
comply with all the Act’s requirements, including, but not limited to: registration and listing (21
CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set
forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic
product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

Page 2 — Mr. William Kelley
This letter will allow you to begin marketing your device as described in your Section 510(k)
premarket notification. The FDA finding of substantial equivalence of your device to a legally
marketed predicate device results in a classification for your device and thus, permits your device to
proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801] and
additionally 21 CFR Part 809.10 for in vitro diagnostic devices), please contact the Office of
Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of
your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the
regulation entitled, “Misbranding by reference to premarket notification” (21 CFR Part 807.97).
Other general information on your responsibilities under the Act may be obtained from the Division
of Small Manufacturers, International and Consumer Assistance at its toll-free number (800)
638-2041 or (301) 443-6597 or at its Internet address
http://www. fda.gov/cdrh/dsma/dsmamain.html

Sincerely yours,

(pecoi . Witten, Ph.D., M.D.
Director
Division of General, Restorative
and Neurological Devices

Office of Device Evaluation

Center for Devices and Radiological Health
Enclosure

INDICATIONS FOR USE STATEMENT
5410(k) Number (if known: KAQACFTY
Device Name: _Laser System BeautyStar 532
Indication For USE Statement:
The BeautyStar 532 is intended for Vaporization and Photocoagulation of
vascular and pigmented lesions in soft tissue.
The laser system BeautyStar is restricted to sale to or use by licensed
professionals in the United States.
(PLEASE DO NOT WRITE BELOW THIS LINE —- CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription owe if + Over-The-Counter Use
(Per 21 CFR 801.109) “A Lite
(Division 'Sign-O
Division of General, Restorative
and Neurological Devices
File: 510k indications for use statement.doc 510(k) Number i< Or \ 7 wa Page 1 of 1

